Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory

Physiology and Behavior

Volumn 155, Issue , 2016, Pages 162-171

  Kutlu, Munir Gunes ^a   Gould, Thomas J ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Addiction; Cell signaling; Hippocampus; Kinases; Learning and memory; Nicotine

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NICOTINE; STRESS ACTIVATED PROTEIN KINASE; NICOTINIC AGENT;

HIPPOCAMPUS; INTRACELLULAR SIGNALING; LEARNING; MEMORY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; NERVE CELL PLASTICITY; PHYSIOLOGY;

ANIMALS; HIPPOCAMPUS; LEARNING; MEMORY; NEURONAL PLASTICITY; NICOTINE; NICOTINIC AGONISTS;

EID: 84949976295     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2015.12.008     Document Type: Review

References (215)

1. Cordero-Erausquin M., et al. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol. Sci. 2000, 21(6):211-217.
2. Le Novere N., Grutter T., Changeux J.-P. Models of the extracellular domain of the nicotinic receptors and of agonist-and Ca2+-binding sites. Proc. Natl. Acad. Sci. 2002, 99(5):3210-3215.
3. Léna C., Changeux J.-P. Allosteric nicotinic receptors, human pathologies. J. Physiol. Paris 1998, 92(2):63-74.
4. Rush R., et al. First and second transmembrane segments of α3, α4, β2, and β4 nicotinic acetylcholine receptor subunits influence the efficacy and potency of nicotine. Mol. Pharmacol. 2002, 61(6):1416-1422.
5. Broide R.S., Leslie F.M. The α7 nicotinic acetylcholine receptor in neuronal plasticity. Mol. Neurobiol. 1999, 20(1):1-16.
6. Perry D.C., et al. Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography. J. Neurochem. 2002, 82(3):468-481.
7. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 1997, 20(2):92-98.
8. Seguela P., et al. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 1993, 13(2):596-604.
9. Wada E., et al. Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 1989, 284(2):314-335.
10. Brown R.W., et al. Nicotinic α5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. J. Neurochem. 2007, 103(1):204-215.
11. Fenster C.P., et al. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J. Neurosci. 1997, 17(15):5747-5759.
12. Fabian-Fine R., et al. Ultrastructural distribution of the α7 nicotinic acetylcholine receptor subunit in rat hippocampus. J. Neurosci. 2001, 21(20):7993-8003.
13. Radcliffe K.A., et al. Nicotinic modulation of glutamate and GABA synaptic transmission in hippocampal neurons. Ann. N. Y. Acad. Sci. 1999, 868(1):591-610.
14. Gahring L.C., et al. Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus. J. Comp. Neurol. 2004, 468(3):334-346.
15. Gahring L.C., Rogers S.W. Nicotinic acetylcholine receptor expression in the hippocampus of 27 mouse strains reveals novel inhibitory circuitry. Hippocampus 2008, 18(8):737-749.
16. Sudweeks S.N., Yakel J.L. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J. Physiol. 2000, 527(3):515-528.
17. Alkondon M., Albuquerque E.X. Nicotinic acetylcholine receptor α7 and α4β2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus. J. Neurophysiol. 2001, 86(6):3043-3055.
18. Jones S., Yakel J.L. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J. Physiol. 1997, 504(3):603-610.
19. McQuiston A.R., Madison D.V. Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J. Neurosci. 1999, 19(8):2887-2896.
20. Alkondon M., et al. Nicotinic acetylcholine receptors and modulation of GABAergic synaptic transmission in the hippocampus. Eur. J. Pharmacol. 2000, 393:59-67.
21. Arqueros L., Naquira D., Zunino E. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol. 1978, 27(23):2667-2674.
22. Barik J., Wonnacott S. Indirect modulation by α7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol. Pharmacol. 2006, 69(2):618-628.
23. Marchi M., et al. Direct evidence that release-stimulating α7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J. Neurochem. 2002, 80(6):1071-1078.
24. Shearman E., et al. Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function. Neurochem. Res. 2005, 30(8):1055-1066.
25. Tani Y., et al. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain-an in vivo microdialysis study. Eur. J. Pharmacol. 1998, 351(2):181-188.
26. Tucci S., Genn R., File S. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of α7 receptors. Neuropharmacology 2003, 44(3):367-373.
27. Abel T., Nguyen P.V. Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. Prog. Brain Res. 2008, 169:97-115.
28. Nguyen P., Woo N. Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog. Neurobiol. 2003, 71(6):401-437.
29. Aggleton J.P., Hunt P., Rawlins J. The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav. Brain Res. 1986, 19(2):133-146.
30. Burgess N., Maguire E.A., O'Keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002, 35(4):625-641.
31. Daumas S., et al. Encoding, consolidation, and retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 hippocampal subregions. Learn. Mem. 2005, 12(4):375-382.
32. Jung M., McNaughton B. Spatial selectivity of unit activity in the hippocampal granular layer. Hippocampus 1993, 3(2):165-182.
33. Amaral D., Lavenex P. Hippocampal neuroanatomy. The hippocampus book. 2007, 3:37-114.
34. Gilbert P.E., Kesner R.P., Lee I. Dissociating hippocampal subregions: a double dissociation between dentate gyrus and CA1. Hippocampus 2001, 11(6):626-636.
35. Lee I., Kesner R.P. Encoding versus retrieval of spatial memory: double dissociation between the dentate gyrus and the perforant path inputs into CA3 in the dorsal hippocampus. Hippocampus 2004, 14(1):66-76.
36. Rolls E.T., Kesner R.P. A computational theory of hippocampal function, and empirical tests of the theory. Prog. Neurobiol. 2006, 79(1):1-48.
37. Gilbert P.E., Kesner R.P. Localization of function within the dorsal hippocampus: the role of the CA3 subregion in paired-associate learning. Behav. Neurosci. 2003, 117(6):1385.
38. Hoge J., Kesner R.P. Role of CA3 and CA1 subregions of the dorsal hippocampus on temporal processing of objects. Neurobiol. Learn. Mem. 2007, 88(2):225-231.
39. Huerta P.T., et al. Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons. Neuron 2000, 25(2):473-480.
40. Remondes M., Schuman E.M. Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory. Nature 2004, 431(7009):699-703.
41. Vago D.R., Bevan A., Kesner R.P. The role of the direct perforant path input to the CA1 subregion of the dorsal hippocampus in memory retention and retrieval. Hippocampus 2007, 17(10):977-987.
42. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361(6407):31-39.
43. Bliss T.V., Lømo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 1973, 232(2):331-356.
44. Hayashi Y., et al. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 2000, 287(5461):2262-2267.
45. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44(1):5-21.
46. Malinow R. AMPA receptor trafficking and long-term potentiation. Philos. Trans. R. Soc. B Biol. Sci. 2003, 358(1432):707-714.
47. Passafaro M., Piëch V., Sheng M. Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat. Neurosci. 2001, 4(9):917-926.
48. Shi S.-H., et al. Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 2001, 105(3):331-343.
49. Lynch G., et al. Chapter The nature and causes of hippocampal long-term potentiation. Prog. Brain Res. 1990, 83:233-250.
50. Nicoll R., Malenka R. Expression Mechanisms Underlying NMDA Receptor-Dependent Long-Term Potentiation. Ann. N. Y. Acad. Sci. 1999, 868(1):515-525.
51. Malenka R.C., Nicoll R.A. Long-term potentiation--a decade of progress?. Science 1999, 285(5435):1870-1874.
52. Akers R.F., et al. Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 1986, 231(4738):587-589.
53. Frey U., et al. Influence of actinomycin D, a RNA synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in vitro. J. Physiol. 1996, 490(3):703-711.
54. Frey U., et al. Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res. 1988, 452(1):57-65.
55. Klann E., Chen S.-J., Sweatt J.D. Persistent protein kinase activation in the maintenance phase of long-term potentiation. J. Biol. Chem. 1991, 266(36):24253-24256.
56. Krug M., Lössner B., Ott T. Anisomycin blocks the late phase of long-term potentiation in the dentate gyrus of freely moving rats. Brain Res. Bull. 1984, 13(1):39-42.
57. Nguyen P.V., Abel T., Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994, 265(5175):1104-1107.
58. Otani S., et al. Maintenance of long-term potentiation in rat dentate gyrus requires protein synthesis but not messenger RNA synthesis immediately post-tetanization. Neuroscience 1989, 28(3):519-526.
59. Lynch M. Long-term potentiation and memory. Physiol. Rev. 2004, 84(1):87-136.
60. Sigurdsson T., et al. Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharmacology 2007, 52(1):215-227.
61. Araujo D., et al. Characterization of N-[3H] Methylcarbamylcholine Binding Sites and Effect of N-Methylcarbamylcholine on Acetylcholine Release in Rat Brain. J. Neurochem. 1988, 51(1):292-299.
62. Clarke P., Reuben M. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br. J. Pharmacol. 1996, 117(4):595-606.
63. Gray R., et al. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 1996, 383(6602):713-716.
64. Wilkie G., et al. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 1996, 21(9):1141-1148.
65. Zarei M., et al. Distributions of nicotinic acetylcholine receptor α7 and β2 subunits on cultured hippocampal neurons. Neuroscience 1999, 88(3):755-764.
66. Alkondon M., Pereira E., Albuquerque E.X. Mapping the location of functional nicotinic and gamma-aminobutyric acidA receptors on hippocampal neurons. J. Pharmacol. Exp. Ther. 1996, 279(3):1491-1506.
67. Fujii S., et al. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res. 1999, 846(1):137-143.
68. He J., et al. Long-term potentiation induced by nicotine in CA1 region hippocampal slice is Ca2+-dependent. Acta Pharmacol. Sin. 2000, 21:429-432.
69. Ji D., Lape R., Dani J.A. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 2001, 31(1):131-141.
70. Mann E.O., Greenfield S.A. Novel modulatory mechanisms revealed by the sustained application of nicotine in the guinea-pig hippocampus in vitro. J. Physiol. 2003, 551(2):539-550.
71. Matsuyama S., Matsumoto A. Epibatidine Induces Long-Term Potentiation (LTP) via Activation of. ALPHA. 4. BETA. 2 Nicotinic Acetylcholine Receptors (nAChRs) In Vivo in the Intact Mouse Dentate Gyrus: Both. ALPHA. 7 and. ALPHA. 4. BETA. 2 nAChRs Essential to Nicotinic LTP. J. Pharmacol. Sci. 2003, 93(2):180-187.
72. Matsuyama S., et al. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur. J. Neurosci. 2000, 12(10):3741-3747.
73. Karadsheh M.S., et al. Functional characterization of mouse α4β2 nicotinic acetylcholine receptors stably expressed in HEK293T cells. J. Neurochem. 2004, 91(5):1138-1150.
74. Tapia L., Kuryatov A., Lindstrom J. Ca2+ permeability of the (α4) 3 (β2) 2 stoichiometry greatly exceeds that of (α4) 2 (β2) 3 human acetylcholine receptors. Mol. Pharmacol. 2007, 71(3):769-776.
75. Kenney J.W., Gould T.J. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol. Neurobiol. 2008, 38(1):101-121.
76. Shen J.-x., Yakel J.L. Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol. Sin. 2009, 30(6):673-680.
77. Ferrari R., et al. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur. J. Neurosci. 2002, 15(11):1810-1818.
78. Kane J., et al. Regulation of Homer and group I metabotropic glutamate receptors by nicotine. Eur. J. Neurosci. 2005, 21(5):1145-1154.
79. Wang F., et al. Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration. Neuropsychopharmacology 2007, 32(1):103-109.
80. Gao M., et al. Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area. J. Neurosci. 2010, 30(41):13814-13825.
81. Tang B., et al. Modulation of AMPA receptor mediated current by nicotinic acetylcholine receptor in layer I neurons of rat prefrontal cortex. Sci. Rep. 2015, 5.
82. Mitsushima D., Sano A., Takahashi T. A cholinergic trigger drives learning-induced plasticity at hippocampal synapses. Nat. Commun. 2013, 4.
83. Alkondon M., Pereira E.F., Albuquerque E.X. NMDA and AMPA receptors contribute to the nicotinic cholinergic excitation of CA1 interneurons in the rat hippocampus. J. Neurophysiol. 2003, 90(3):1613-1625.
84. Fujii S., Ji Z., Sumikawa K. Inactivation of α7 ACh receptors and activation of non-α7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. Neurosci. Lett. 2000, 286(2):134-138.
85. Welsby P., Rowan M., Anwyl R. Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus. Eur. J. Neurosci. 2006, 24(11):3109-3118.
86. Welsby P.J., Rowan M.J., Anwyl R. Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP. Neuropharmacology 2007, 53(1):188-195.
87. André J.M., et al. Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behav. Brain Res. 2008, 190(2):174-181.
88. Davis J.A., et al. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J. Neurosci. 2005, 25(38):8708-8713.
89. Kenney J.W., et al. The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice. Psychopharmacology (Berlin) 2011, 217(3):353-365.
90. Portugal G.S., Gould T.J. Nicotine withdrawal disrupts new contextual learning. Pharmacol. Biochem. Behav. 2009, 92(1):117-123.
91. Portugal G.S., et al. Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Neurobiol. Learn. Mem. 2012, 97(4):482-494.
92. Raybuck J., Gould T. Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice-a role for high-affinity β2 subunit-containing nicotinic acetylcholine receptors. Eur. J. Neurosci. 2009, 29(2):377-387.
93. Yamazaki Y., et al. Nicotine withdrawal suppresses nicotinic modulation of long-term potentiation induction in the hippocampal CA1 region. Eur. J. Neurosci. 2006, 24(10):2903-2916.
94. Davis J.A., Porter J., Gould T.J. Nicotine enhances both foreground and background contextual fear conditioning. Neurosci. Lett. 2006, 394(3):202-205.
95. Gould T.J. Nicotine produces a within-subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex. Integr. Physiol. Behav. Sci. 2003, 38(2):124-132.
96. Gould T.J., Feiro O., Moore D. Nicotine enhances trace cued fear conditioning but not delay cued fear conditioning in C57BL/6 mice. Behav. Brain Res. 2004, 155(1):167-173.
97. Gould T.J., Higgins J.S. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiol. Learn. Mem. 2003, 80(2):147-157.
98. Gould T.J., Wehner J.M. Nicotine enhancement of contextual fear conditioning. Behav. Brain Res. 1999, 102(1):31-39.
99. Wehner J., et al. Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning. Neuroscience 2004, 129(1):11-24.
100. Davis J.A., Kenney J.W., Gould T.J. Hippocampal α4β2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J. Neurosci. 2007, 27(40):10870-10877.
101. Szyndler J., et al. The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats. Pharmacol. Biochem. Behav. 2001, 69(3):511-518.
102. Kenney J.W., Gould T.J. Nicotine enhances context learning but not context-shock associative learning. Behav. Neurosci. 2008, 122(5):1158.
103. Abdulla F., et al. Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology (Berlin) 1996, 124(4):323-331.
104. Sharifzadeh M., et al. Post-training intrahippocampal infusion of nicotine prevents spatial memory retention deficits induced by the cyclo-oxygenase-2-specific inhibitor celecoxib in rats. J. Neurochem. 2005, 95(4):1078-1090.
105. Levin E., Kaplan S., Boardman A. Acute nicotine interactions with nicotinic and muscarinic antagonists: Working and reference memory effects in the 16-arm radial maze. Behav. Pharmacol. 1997.
106. Levin E.D., et al. Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze. Pharmacol. Biochem. Behav. 1998, 61(3):335-340.
107. Levin E.D., Torry D. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berlin) 1996, 123(1):88-97.
108. Bernal M., et al. Effects of nicotine on spatial learning in C57BL mice. Behav. Pharmacol. 1999, 10(3):333-336.
109. Socci D.J., Sanberg P.R., Arendash G.W. Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol. Aging 1995, 16(5):857-860.
110. Scerri C., et al. The effects of chronic nicotine on spatial learning and bromodeoxyuridine incorporation into the dentate gyrus of the rat. Psychopharmacology (Berlin) 2006, 184(3-4):540-546.
111. Matta S.G., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berlin) 2007, 190(3):269-319.
112. Loughead J., et al. Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology 2014.
113. Patterson F., et al. Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend. 2010, 106(1):61-64.
114. Rukstalis M., et al. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J. Subst. Abus. Treat. 2005, 28(4):297-304.
115. Bardo M., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berlin) 2000, 153(1):31-43.
116. Calcagnetti D.J., Schechter M.D. Nicotine place preference using the biased method of conditioning. Prog. Neuropsychopharmacol. Biol. Psychiatry 1994, 18(5):925-933.
117. Kutlu M.G., Ortega L.A., Gould T.J. Strain-dependent performance in nicotine-induced conditioned place preference. Behav. Neurosci. 2015, 129(1):37.
118. Murray A.J. Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal. 2008, 1(22):re4.
119. Impey S., et al. Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat. Neurosci. 1998, 1(7):595-601.
120. Silva A.J., et al. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 1992, 257(5067):206-211.
121. Ahi J., Radulovic J., Spiess J. The role of hippocampal signaling cascades in consolidation of fear memory. Behav. Brain Res. 2004, 149(1):17-31.
122. Ma N., Abel T., Hernandez P.J. Exchange protein activated by cAMP enhances long-term memory formation independent of protein kinase A. Learn. Mem. 2009, 16(6):367-370.
123. Wallenstein G.V., Vago D.R., Walberer A.M. Time-dependent involvement of PKA/PKC in contextual memory consolidation. Behav. Brain Res. 2002, 133(2):159-164.
124. Abel T., et al. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 1997, 88(5):615-626.
125. Huang Y.-Y., Kandel E.R. Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization. Learn. Mem. 1994, 1(1):74-82.
126. Nguyen P.V., Kandel E.R. Brief theta-burst stimulation induces a transcription-dependent late phase of LTP requiring cAMP in area CA1 of the mouse hippocampus. Learn. Mem. 1997, 4(2):230-243.
127. Dajas-Bailador F., Soliakov L., Wonnacott S. Nicotine activates the extracellular signal-regulated kinase 1/2 via the α7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J. Neurochem. 2002, 80(3):520-530.
128. Gopalakrishnan M., Molinari E.J., Sullivan J.P. Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol. Pharmacol. 1997, 52(3):524-534.
129. Guo X., Wecker L. Identification of three cAMP-dependent protein kinase (PKA) phosphorylation sites within the major intracellular domain of neuronal nicotinic receptor α4 subunits. J. Neurochem. 2002, 82(2):439-447.
130. Hou J., et al. Repetitive exposures to nicotine induce a hyper-responsiveness via the cAMP/PKA/CREB signal pathway in Drosophila. J. Neurobiol. 2004, 60(2):249-261.
131. Hsu Y.-N., Edwards S.C., Wecker L. Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of a4 subunits of neuronal nicotinic receptors. J. Neurochem. 1997, 69:2427-2431.
132. Nakayama H., Okuda H., Nakashima T. Phosphorylation of rat brain nicotinic acetylcholine receptor by cAMP-dependent protein kinase in vitro. Mol. Brain Res. 1993, 20(1):171-177.
133. Nishizaki T., Sumikawa K. Effects of PKC and PKA phosphorylation on desensitization of nicotinic acetylcholine receptors. Brain Res. 1998, 812(1):242-245.
134. Pollock V.V., et al. Cyclic AMP-dependent protein kinase A and protein kinase C phosphorylate α4β2 nicotinic receptor subunits at distinct stages of receptor formation and maturation. Neuroscience 2009, 158(4):1311-1325.
135. Wecker L., et al. Cyclic AMP-dependent protein kinase (PKA) and protein kinase C phosphorylate sites in the amino acid sequence corresponding to the M3/M4 cytoplasmic domain of α4 neuronal nicotinic receptor subunits. J. Neurochem. 2001, 76(3):711-720.
136. Wang H., Sun X. Desensitized nicotinic receptors in brain. Brain Res. Rev. 2005, 48(3):420-437.
137. Paradiso K., Brehm P. Long-term desensitization of nicotinic acetylcholine receptors is regulated via protein kinase A-mediated phosphorylation. J. Neurosci. 1998, 18(22):9227-9237.
138. Welsby P.J., Rowan M.J., Anwyl R. Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus. Eur. J. Neurosci. 2009, 29(1):65-75.
139. Gould T.J., Leach P.T. Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning. Neurobiol. Learn. Mem. 2014, 107:108-132.
140. Matthews R.P., et al. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol. 1994, 14(9):6107-6116.
141. Lisman J., Schulman H., Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev. Neurosci. 2002, 3(3):175-190.
142. Kasahara J., Fukunaga K., Miyamoto E. Activation of calcium/calmodulin-dependent protein kinase IV in long term potentiation in the rat hippocampal CA1 region. J. Biol. Chem. 2001, 276(26):24044-24050.
143. Bayer K.-U., et al. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 2001, 411(6839):801-805.
144. Selbert M.A., et al. Phosphorylation and Activation of Ca-Calmodulin-dependent Protein Kinase IV by Ca-Calmodulin-dependent Protein Kinase Ia Kinase PHOSPHORYLATION OF THREONINE 196 IS ESSENTIAL FOR ACTIVATION. J. Biol. Chem. 1995, 270(29):17616-17621.
145. Cammarota M., et al. Participation of CaMKII in neuronal plasticity and memory formation. Cell. Mol. Neurobiol. 2002, 22(3):259-267.
146. Malinow R., Schulman H., Tsien R.W. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 1989, 245(4920):862-866.
147. Ito I., Hidaka H., Sugiyama H. Effects of KN-62, a specific inhibitor of calcium/calmodulin-dependent protein kinase II, on long-term potentiation in the rat hippocampus. Neurosci. Lett. 1991, 121(1):119-121.
148. Hinds H.L., Tonegawa S., Malinow R. CA1 long-term potentiation is diminished but present in hippocampal slices from α-CaMKII mutant mice. Learn. Mem. 1998, 5(4):344-354.
149. Ouyang Y., et al. Tetanic stimulation leads to increased accumulation of Ca2+/calmodulin-dependent protein kinase II via dendritic protein synthesis in hippocampal neurons. J. Neurosci. 1999, 19(18):7823-7833.
150. Bach M.E., et al. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the θ frequency. Cell 1995, 81(6):905-915.
151. Wang H., et al. CaMKII activation state underlies synaptic labile phase of LTP and short-term memory formation. Curr. Biol. 2008, 18(20):1546-1554.
152. Arredondo J., et al. Receptor-mediated tobacco toxicity: acceleration of sequential expression of α5 and α7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke. FASEB J. 2008, 22(5):1356-1368.
153. Liu Q.-s., Berg D.K. Actin filaments and the opposing actions of CaM kinase II and calcineurin in regulating α7-containing nicotinic receptors on chick ciliary ganglion neurons. J. Neurosci. 1999, 19(23):10280-10288.
154. Ridley D.L., Rogers A., Wonnacott S. Differential effects of chronic drug treatment on α3* and α7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. Br. J. Pharmacol. 2001, 133(8):1286-1295.
155. Zhang J., Berg D.K. Reversible inhibition of GABAA receptors by α7-containing nicotinic receptors on the vertebrate postsynaptic neurons. J. Physiol. 2007, 579(3):753-763.
156. Jackson K.J., Walters C.L., Damaj M.I. β2 subunit-containing nicotinic receptors mediate acute nicotine-induced activation of calcium/calmodulin-dependent protein kinase II-dependent pathways in vivo. J. Pharmacol. Exp. Ther. 2009, 330(2):541-549.
157. Steiner R.C., Heath C.J., Picciotto M.R. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII. J. Neurochem. 2007, 103(2):666-678.
158. Hoshi M., Nishida E., Sakai H. Activation of a Ca2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts. J. Biol. Chem. 1988, 263(11):5396-5401.
159. Boulton T.G., et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991, 65(4):663-675.
160. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 1995, 9(9):726-735.
161. Atkins C.M., et al. The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1998, 1(7):602-609.
162. English J.D., Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 1997, 272(31):19103-19106.
163. Coogan A.N., O'Leary D.M., O'Connor J.J. P42/44 MAP kinase inhibitor PD98059 attenuates multiple forms of synaptic plasticity in rat dentate gyrus in vitro. J. Neurophysiol. 1999, 81(1):103-110.
164. English J.D., Sweatt J.D. Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J. Biol. Chem. 1996, 271(40):24329-24332.
165. Winder D.G., et al. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by β-adrenergic receptors. Neuron 1999, 24(3):715-726.
166. Cammarota M., et al. Learning-associated activation of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat hippocampus after a one-trial avoidance learning: abolition by NMDA receptor blockade. Mol. Brain Res. 2000, 76(1):36-46.
167. Sananbenesi F., et al. Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1. Mol. Cell. Neurosci. 2002, 21(3):463-476.
168. Schafe G.E., et al. Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J. Neurosci. 2000, 20(21):8177-8187.
169. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 2004, 14(3):311-317.
170. Valjent E., et al. Possible role of the extracellular signal-regulated kinase (ERK) in reward-controlled learning and addiction. Curr. Neuropharmacol. 2003, 1(2):165-174.
171. Trifilieff P., et al. Foreground contextual fear memory consolidation requires two independent phases of hippocampal ERK/CREB activation. Learn. Mem. 2006, 13(3):349-358.
172. Satoh Y., et al. Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. J. Neurosci. 2007, 27(40):10765-10776.
173. Selcher J.C., et al. A necessity for MAP kinase activation in mammalian spatial learning. Learn. Mem. 1999, 6(5):478-490.
174. Shalin S.C., et al. Neuronal MEK is important for normal fear conditioning in mice. J. Neurosci. Res. 2004, 75(6):760-770.
175. Gould T.J., et al. Nicotine shifts the temporal activation of hippocampal protein kinase A and extracellular signal-regulated kinase 1/2 to enhance long-term, but not short-term, hippocampus-dependent memory. Neurobiol. Learn. Mem. 2014, 109:151-159.
176. Neugebauer N.M., et al. Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacol. Biochem. Behav. 2011, 98(1):87-93.
177. Valjent E., et al. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur. J. Neurosci. 2004, 19(7):1826-1836.
178. Nakayama H., et al. Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. J. Neurochem. 2001, 79(3):489-498.
179. Nuutinen S., et al. Differential effects of acute and chronic nicotine on Elk-1 in rat hippocampus. Neuroreport 2007, 18(2):121-126.
180. Wang J., et al. Activation of p42/44 mitogen-activated protein kinase pathway in long-term potentiation induced by nicotine in hippocampal CA1 region in rats. Acta Pharmacol. Sin. 2001, 22(8):685-690.
181. Raybuck J.D., Gould T.J. Extracellular signal-regulated kinase 1/2 involvement in the enhancement of contextual fear conditioning by nicotine. Behav. Neurosci. 2007, 121(5):1119.
182. Kenney J.W., et al. Involvement of hippocampal jun-N terminal kinase pathway in the enhancement of learning and memory by nicotine. Neuropsychopharmacology 2010, 35(2):483.
183. Kenney J.W., et al. Learning and nicotine interact to increase CREB phosphorylation at the jnk1 promoter in the hippocampus. PLoS ONE 2012, 7(6):e39939.
184. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410(6824):37-40.
185. Gupta S., et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 1996, 15(11):2760.
186. Chen Y.-R., Meyer C.F., Tan T.-H. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in γ radiation-induced apoptosis. J. Biol. Chem. 1996, 271(2):631-634.
187. Faris M., et al. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol. 1998, 160(1):134-144.
188. Ham J., et al. c-Jun and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 2000, 60(8):1015-1021.
189. Björkblom B., et al. Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J. Neurosci. 2005, 25(27):6350-6361.
190. Chang L., et al. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev. Cell 2003, 4(4):521-533.
191. Gelderblom M., et al. c-Jun N-terminal kinases (JNKs) and the cytoskeleton-functions beyond neurodegeneration. Int. J. Dev. Neurosci. 2004, 22(7):559-564.
192. Bevilaqua L.R., et al. Inhibition of hippocampal Jun N-terminal kinase enhances short-term memory but blocks long-term memory formation and retrieval of an inhibitory avoidance task. Eur. J. Neurosci. 2003, 17(4):897-902.
193. Leach P.T., Kenney J.W., Gould T.J. Stronger learning recruits additional cell-signaling cascades: c-Jun-N-terminal kinase 1 (JNK1) is necessary for expression of stronger contextual fear conditioning. Neurobiol. Learn. Mem. 2015, 118:162-166.
194. Li X.M., et al. JNK1 contributes to metabotropic glutamate receptor-dependent long-term depression and short-term synaptic plasticity in the mice area hippocampal CA1. Eur. J. Neurosci. 2007, 25(2):391-396.
195. Haeusgen W., et al. Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience 2009, 161(4):951-959.
196. Costello D.A., Herron C.E. The role of c-Jun N-terminal kinase in the Aβ-mediated impairment of LTP and regulation of synaptic transmission in the hippocampus. Neuropharmacology 2004, 46(5):655-662.
197. Wang Q., et al. Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 2004, 24(13):3370-3378.
198. Curran B., Murray H., O'Connor J. A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1β and long-term depression in the rat dentate gyrus in vitro. Neuroscience 2003, 118(2):347-357.
199. Sherrin T., et al. Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning. J. Neurosci. 2010, 30(40):13348-13361.
200. Carlezon W.A., Duman R.S., Nestler E.J. The many faces of CREB. Trends Neurosci. 2005, 28(8):436-445.
201. Abel T., Lattal K.M. Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr. Opin. Neurobiol. 2001, 11(2):180-187.
202. Bourtchuladze R., et al. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994, 79(1):59-68.
203. Ying S.-W., et al. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J. Neurosci. 2002, 22(5):1532-1540.
204. Wood M.A., et al. Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn. Mem. 2005, 12(2):111-119.
205. Barco A., Alarcon J.M., Kandel E.R. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 2002, 108(5):689-703.
206. Pittenger C., et al. Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 2002, 34(3):447-462.
207. Mizuno M., et al. CREB phosphorylation as a molecular marker of memory processing in the hippocampus for spatial learning. Behav. Brain Res. 2002, 133(2):135-141.
208. Gass P., et al. Deficits in memory tasks of mice with CREB mutations depend on gene dosage. Learn. Mem. 1998, 5(4):274-288.
209. Graves L., et al. Behavioral analysis of CREB αδ mutation on a B6/129 F1 hybrid background. Hippocampus 2002, 12(1):18-26.
210. Restivo L., et al. Viral-mediated expression of a constitutively active form of CREB in hippocampal neurons increases memory. Hippocampus 2009, 19(3):228-234.
211. Hu M., et al. Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathways. Mol. Cell. Neurosci. 2002, 21(4):616-625.
212. Pascual M.M., Pastor V., Bernabeu R.O. Nicotine-conditioned place preference induced CREB phosphorylation and Fos expression in the adult rat brain. Psychopharmacology (Berlin) 2009, 207(1):57-71.
213. Chang K.T., Berg D.K. Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron 2001, 32(5):855-865.
214. Davis J.A., Gould T.J. β2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berlin) 2007, 190(3):343-352.
215. Raybuck J., Gould T. The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning. Neurobiol. Learn. Mem. 2010, 94(3):353-363.